NCT06822829
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy
Clinical trial condition
Explore clinical trials studying Indolent B Cell Lymphoma. Study availability and eligibility vary by location and protocol.
NCT06822829
NCT03019666